Smith+Nephew announced the acquisition of Integrity Orthopaedics, a U.S.‑based early‑stage commercial developer of Tendon Seam, a rotator cuff repair (RCR) system designed to significantly reduce re‑tear rates and improve patient outcomes.
Under the terms of the transaction, Smith+Nephew will provide an initial cash payment of $225 million plus additional performance-based payments of up to $225 million over the next five years. The transaction is expected to close before the end of January 2026.
Tendon Seam features patented micro‑anchors, continuous suture, individually locked stitches, and integrated implantation instrument are designed to deliver stronger repairs, accelerated patient recovery, lower re‑tear rates, and a simplified surgical technique. Early clinical experience indicates low re‑tear rates, reduced sling times and shorter procedures compared with standard methods. The system received 510(k) clearance in 2023 and is indicated for reattachment of soft tissue to bone, including tendons, ligaments, and joint capsules.
Integrity Orthopaedics was founded in 2020 and is headquartered in Maple Plain, Minnesota. Its founders include Tom Westling, co-founder of Rotation Medical, the developer of the REGENETEN Bioinductive Implant, which was acquired by Smith+Nephew in 2017.
